合并糖尿病的毒性甲状腺肿患者内分泌疾病的治疗  

Treatment for patients with endocrine disorders complicating diabetes mellitus

作　　者：黄汉乔[1] Huang Hanqiao(Department of Internal Medicine,Guigang Orthopedic Hospital of Chinese and Western Medicine,Guigang 537100,China)

机构地区：[1]贵港市中西医结合骨科医院内科,537100

出　　处：《国际医药卫生导报》2018年第8期1240-1242,共3页International Medicine and Health Guidance News

摘　　要：目的 观察、分析在合并糖尿病的毒性甲状腺肿患者内分泌疾病的治疗效果。方法 选取本院接收的合并糖尿病的毒性甲状腺肿患者84例作为研究对象，分为两组，每组42例。对照组应用常规药物治疗路径；实验组应用环磷酞胺联合甲强龙治疗路径。观察分析两组的治疗效果。结果 实验组患者的治疗总有效率为92.9%，高于对照组患者的治疗总有效率78.6%，差异有统计学意义（P＜0.05）；实验组患者的治疗满意度为97.6%，对照组为83.3%，实验组明显优于对照组，差异有统计学意义（P＜0.05）。结论 在合并糖尿病的毒性甲状腺肿患者的治疗中，相比于应用常规药物治疗路径来说，应用环磷酞胺联合甲强龙治疗路径的治疗效果更为显著，患者的治疗满意度高，值得应用。Objective To observe and analyze the therapeutic effect of patients with endocrine disorders complicating diabetes mellitus.Methods 84 patients with toxic goiter complicating diabetes mellitus treated at our hospital were selected as study objects and divided into a control group and an experimental group,42 for each group.The control group were treated with routine drugs.The experimental group were treated with cyclophosphamide and methylprednisolone.The treatment effects in both groups were observed and analyzed.Results The total effective rate was 92.9%in the experimental group and was 78.6%in the control group,with a statistical difference(P<0.05).The satisfaction degree was 97.6%in the experimental group and was 83.3%in the control group,with statistical difference(P<0.05).Conclusion Cyclophosphamide and methylprednisolone for patients with toxic goiter complicating diabetes mellitus is more effective than routine drugs and the patients have higher satisfaction degree,so it is worth for application.

关 键 词：合并糖尿病 毒性甲状腺肿 内分泌疾病 

分 类 号：R581.3[医药卫生—内分泌] R587.1[医药卫生—内科学]